Andrey Lisitsa (Academician of the Russian Academy of Sciences), Alexander Lavrov (the Russian Research Centre of Medical Genetics), Nikolay Sergeev (CTO of a startup), XueLiang (CTO of Yaneng Bio), Yang Haitao (Chairman of Zhuhai Biocode), LiJingxiang(Executive Director of Strategic Investment Center of BGI Group). In the guest roundtable forum under the theme of “Microfluidic Biochip Development Status and Application Market Prospects” and “Genetic Sequencing Clinical Application
1.Smart biochip revolutionizes sequencing [Gene Club]Dr. Tian, first of all congratulate Axbio on the sequencer and smart biochip conference successfully held, what is your greatest feeling at this moment? What do you want to say to your team and Gene Club readers? [Tian Hui] Thank you! As an entrepreneur, I am very happy with today’s
On June 28, 2019, Axbio held a new product launch conference themed as “Smartness Leads to Changes” at the Courtyard by Marriott Shenzhen Bay.
Axbio and TowerJazz Announces Successful Development of In-Vitro Diagnostic Bio-CMOS IC using its Advanced 300mm 65nm RFCMOS Platformd!
Breakthrough device planned to be inproduction by mid 2019, offering frontier solution for the medical market